Evoke plc (LON:EVOK – Get Free Report) shares fell 10% on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares were traded during mid-day trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analyst Weigh In
Several research firms recently weighed in on EVOK. Berenberg Bank dropped their price objective on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a research note on Wednesday, December 4th. Jefferies Financial Group restated a “buy” rating and set a GBX 140 ($1.81) target price on shares of Evoke in a report on Monday, December 16th.
Check Out Our Latest Stock Analysis on Evoke
Evoke Stock Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. As a group, research analysts forecast that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insider Transactions at Evoke
In related news, insider Andrea Gisle Joosen purchased 14,572 shares of the firm’s stock in a transaction on Tuesday, January 28th. The shares were bought at an average price of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Insiders own 27.00% of the company’s stock.
About Evoke
Featured Articles
- Five stocks we like better than Evoke
- Low PE Growth Stocks: Unlocking Investment Opportunities
- MarketBeat Week in Review – 03/24 – 03/28
- Pros And Cons Of Monthly Dividend Stocks
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- How to Buy Cheap Stocks Step by Step
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.